A group of 39 civil society organisations, including SOMO is calling on the European Commission and EU national governments to ensure a maximum degree of transparency in the EU’s exchanges, negotiations and deals with pharmaceutical…
The total control of drug development by pharmaceutical companies is both problematic and unsustainable. Pharmaceutical companies are often more concerned about profits than public health priorities or corporate accountability.
As a result, key health priorities are neglected and people lack access to the medicine they need. Companies engage in harmful and unethical research practices, and irresponsible marketing practices.
SOMO researches the policies and practices around pharmaceutical drug development, with a particular focus on the ethics of drug testing in low and middle income countries. Clinical trials in these countries often involve vulnerable people, raising serious ethical questions.
We push pharmaceutical companies to act with due diligence in line with the UN Guiding Principles on Business and Human Rights in relation to peoples’ participation in clinical trials, as well as Post-Trial Access (PTA) to medicine.read more less
Sustainable Supply Chains
Many of the problems facing people in middle and low income countries (indirectly) result from the practices and policies of multinational corporations at the end of the supply chain.
Bad working conditions and unsustainable practices
Many people in these sectors are working under inhumane and dangerous conditions with little or no respect for labour rights or environmental standards. Excessive hours, low wages and precarious employment conditions are common in supply chains of the garments, electronics and food sectors. It’s no coincidence that those who are especially vulnerable to abuse and exploitation – migrants, young people and women – are heavily employed in these sectors.
Binding regulations and good practices
Together with trade unions and other civil society organisations, SOMO presses for the promotion and protection of the rights of workers, communities and individuals in all stages of supply chains. SOMO pushes for regulation, policies and practices that ensure decent work and sustainability, including legally enforceable corporate accountability mechanisms and a leading role for workers in monitoring and ensuring improvement of workplace conditions. SOMO promotes sustainable public procurement which, by mobilising the massive purchasing power of the public sector, can bring about structural improvements in supply chains.